Physician profile
Tackson Tam
NPI 1548239635
$3,315.30
in general payments reported to CMS, 2019-2025
29 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,679 · 2020: $583 · 2021: $33.65 · 2022: $19.78.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $369.55 | 2019-2020 | |
| Glaxosmithkline, LLC. | $310.44 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $230.72 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $229.86 | 2019-2020 | |
| Lilly USA, LLC | $227.71 | 2019-2020 | |
| Amarin Pharma, INC. | $224.61 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $216.37 | 2019-2020 | |
| Pfizer INC. | $213.98 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $188.88 | 2019-2020 | |
| Novo Nordisk INC | $179.65 | 2019 | |
| Novartis Pharmaceuticals Corporation | $150.76 | 2019-2020 | |
| Philips North America LLC | $124.16 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $68.31 | 2019 | |
| Merck Sharp & Dohme LLC | $64.49 | 2019 | |
| Allergan, INC. | $62.62 | 2019-2020 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $52.20 | 2019 | |
| Astellas Pharma US INC | $46.71 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $42.34 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $42.29 | 2019 | |
| Scilex Pharmaceuticals INC. | $41.28 | 2019-2020 | |
| Aytu Biopharma, INC. | $40.53 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $37.55 | 2020 | |
| Abbvie INC. | $36.66 | 2019-2020 | |
| Sanofi Pasteur INC. | $26.07 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $24.07 | 2019 | |
| Phadia US INC. | $18.74 | 2020 | |
| Arbor Pharmaceuticals, INC. | $17.42 | 2019 | |
| Antares Pharma, INC. | $15.62 | 2019 | |
| Mayne Pharma Commercial LLC | $11.71 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tackson Tam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.